دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
ویرایش: نویسندگان: Amin Reza Rajabzadeh, Seshasai Srinivasan, Poushali Das, Sayan Ganguly سری: ISBN (شابک) : 9781003319870 ناشر: CRC Press سال نشر: 2023 تعداد صفحات: 304 [305] زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 55 Mb
در صورت ایرانی بودن نویسنده امکان دانلود وجود ندارد و مبلغ عودت داده خواهد شد
در صورت تبدیل فایل کتاب Magnetic Quantum Dots for Bioimaging به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب نقاط کوانتومی مغناطیسی برای تصویربرداری زیستی نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
نقاط کوانتومی بسیار درخشان همراه با نانوذرات یا یون های مغناطیسی یک کلاس هیجان انگیز از مواد جدید برای تصویربرداری زیستی را تشکیل می دهند. این کتاب تحقیقات پیشرو در ساخت، خصوصیات، خواص و کاربرد نقاط کوانتومی مغناطیسی در تصویربرداری زیستی را بررسی میکند.
Highly luminescent quantum dots combined with magnetic nanoparticles or ions form an exciting class of new materials for bioimaging. The book explores leading research in the fabrication, characterization, properties, and application of magnetic quantum dots in bioimaging.
Cover Half Title Title Page Copyright Page Table of Contents Editors Contributors 1 Introduction to Magnetic Quantum Dots 1.1 Introduction 1.2 Types of Imaging Probes 1.3 Nanoparticles and Their Types 1.4 Quantum Dots 1.5 Magnetic Quantum Dots 1.6 Magnetic Nanoparticles (MNPs) 1.7 Limitations of MNPs and Quantum Dots in Bioimaging 1.8 Types of MQDs 1.9 Fundamental Properties of MQDs 1.10 Criteria for the Preparation of Magnetic Quantum Dots 1.11 Synthesis of Magnetic Quantum Dots 1.12 Characterization of Magnetic Quantum Dots 1.13 Application of Magnetic Quantum Dots 1.14 Toxicity Concern for Magnetic Quantum Dots 1.15 Conclusion and Future Prospects References 2 Synthesis Approaches of Magnetic Quantum Dots 2.1 Introduction 2.2 Synthesis Methods of MQDs 2.2.1 Heterocrystalline Growth 2.2.2 Encapsulation and Assembly Method 2.2.2.1 MQDs Embedded in Silica Matrix 2.2.2.2 MQDs Embedded in Polymer Beads or Micelles 2.2.3 Doping of Paramagnetic Transition Metal Ions or Iron Ions Into QDs 2.2.4 Miscellaneous Methods for MQD Synthesis 2.3 Conclusions and Future Outlook References 3 Optical Properties of Magnetic Quantum Dots 3.1 Introduction 3.2 Theoretical Background 3.2.1 Mn Doping in II-VI QDs 3.2.2 Mn Doping in III-V QDs 3.3 Optical Properties of Magnetic Quantum Dots 3.3.1 Oscillator Strength 3.3.2 Refractive Index 3.3.3 Absorption Coefficient 3.4 Tailoring of Optical Properties for Biological Applications 3.4.1 Multimodal Imaging 3.4.2 Molecular Detection and Separation 3.4.3 Theranostics 3.5 Toxicity 3.6 Conclusion Acknowledgements References 4 Characterization Techniques of Magnetic Quantum Dots 4.1 Introduction 4.2 Tools and Techniques for Characterization 4.2.1 Scattering Analysis 4.2.2 X-Ray Characterization 4.2.2.1 Rietveld Refinement 4.2.3 Spectroscopic Analysis 4.2.3.1 UV-Visible Spectroscopy 4.2.3.2 Photoluminescence Spectroscopy 4.2.3.3 Optical Analysis Using Derivative Spectroscopy 4.2.4 Microscopic Techniques for Nanostructure Characterization 4.2.4.1 FESEM Analysis 4.2.4.2 HRTEM Analysis 4.2.5 Magnetic Characterization 4.2.5.1 VSM Analysis 4.2.5.2 Deep Insight Into Magnetic Results Using Derivative Spectroscopy 4.2.6 FT-IR Analysis 4.3 Key Notes 4.4 Conclusion and Future Perspectives References 5 History and Techniques of Bioimaging 5.1 Evolution of Imaging: Brief Introduction 5.2 Bioimaging: Definition 5.3 Bioimaging: Initial Developments 5.3.1 Bioimaging Modalities: An Overview 5.3.1.1 X-Ray Radiography 5.3.1.2 Computed Tomography 5.3.1.3 Magnetic Resonance Imaging (MRI) 5.3.1.4 Ultrasonography 5.3.1.5 Positron Emission Tomography 5.3.1.6 Single-Photon Emission Computerized Tomography 5.4 Advancements in Bioimaging: Molecular and Cellular Imaging 5.5 Evolution of Molecular Probes and Quantum Dots in Bioimaging 5.5.1 Magnetic Resonance Imaging Contrast Agents 5.5.2 CT Contrast Agents 5.5.3 Positron Emission Tomography and Single-Photon Emitted Tomography 5.5.4 Optical Imaging: Fluorescence Microscopy and Quantum Dots 5.6 Conclusion References 6 Fluorescent Magnetic Quantum Dots in Bioimaging 6.1 Introduction 6.2 Synthesis of Fluorescent Magnetic Quantum Dots 6.2.1 High-Temperature Decomposition 6.2.2 Doping 6.2.3 Crosslinking 6.2.4 Encapsulation 6.3 Types of Magnetic Quantum Dots 6.3.1 Core/Shell and Heterostructures (Type I) 6.3.2 Doped QDs (Type II) 6.3.3 Composite Particles Containing Semiconducting Nanoparticles and MNPs (Type III) 6.3.4 QDs With a Paramagnetic Coating of Gd-Chelates (Type IV) 6.4 Applications of Fluorescent-Magnetic Nanoparticles 6.4.1 Multimodal Imaging 6.4.2 Detection and Separation 6.4.3 Theranostics 6.4.4 Magnetic-Activated Cell Sorting (MACS) 6.5 Conclusion References 7 Magnetic Quantum Dots for Magnetic Resonance Imaging (MRI) and Biomedical Applications 7.1 Introduction 7.2 Different Types of MQDs 7.3 MNP/QDs Heterostructures for MRI 7.4 Doped QDs for MRI 7.5 QDs With Porous Material Nanoparticles for MRI 7.6 Gd Chelates Conjugated QD for MRI 7.7 Conclusion and Future Perspectives References 8 A Siege Cancer Phototherapies By Magnetic Quantum Dots: An Overview, Challenges, and Recent Advancements 8.1 Cancer Phototherapies 8.2 Photodynamic Therapy (PDT) in Cancer Treatments 8.2.1 Mechanism 8.2.2 Limitations of PDT 8.2.2.1 Inherent Photosensitizers 8.2.2.2 Tissue Oxygen 8.2.2.3 Density of Light 8.2.3 Solution to the Drawbacks of PDT 8.3 Photothermal Therapy (PTT) in Cancer Treatments 8.3.1 Mechanism 8.3.2 Limitations of PTT 8.3.2.1 Thermal Damage to Normal Tissue 8.3.2.2 Insufficient Photothermal Effect 8.3.3 Solution to the Drawbacks of PTT 8.4 Recent Advancements of Magnetic Quantum Dots in Cancer Phototherapies 8.4.1 Metallic M-QDs 8.4.1.1 Iron Oxide M-QDs 8.4.1.2 Gold M-QDs 8.4.1.3 Silver M-QDs 8.4.1.4 Manganese M-QDs 8.4.1.5 Molybdenum M-QDs 8.4.1.6 Zinc M-QDs 8.4.2 Metallic Semi-Conductor Quantum Dots (MSCQDs) 8.4.3 Carbon-Based M-QDs 8.4.3.1 Graphene Quantum Dots (GQDs) 8.4.3.2 Carbon Dots (C-DOTs) 8.4.4 Hybrid M-QDs 8.5 Clinical Interference of Phototherapies References 9 Magnetic Quantum Dots for In-Vitro Imaging 9.1 Introduction 9.2 Synthesis of Magnetic Quantum Dots 9.3 Magnetic Quantum Dots for In-Vitro Imaging 9.4 Challenges and Future Perspective 9.5 Conclusion References 10 Magnetic Quantum Dots for In-Vivo Imaging 10.1 Introduction 10.2 Photo Physical Properties of Quantum Dots 10.3 Advantages of QDs in Bioimaging 10.4 Synthetic Methods of Magnetic Quantum Dots 10.4.1 Synthesis of MQDs By Hetero-Crystalline Growth 10.4.2 Synthesis of MQDs By Doping 10.4.3 Synthesis of MQDs By Cross-Linking 10.4.4 Synthesis of MQDs By the Encapsulation Method 10.5 Nanoprobes for Multimodal Imaging Using Fluorescent and Magnetic Quantum Dots 10.6 Applications of MQDs in In-Vivo Imaging 10.7 Conclusion Acknowledgements References 11 Carbon Quantum Dots-Based Magnetic Nanoparticles for Bioimaging 11.1 Introduction 11.2 Synthesis Procedures of Magnetic Quantum Dots 11.3 Magnetic QDs for Imaging Applications 11.4 Supported Matrix Magnetic QDs for Imaging Applications 11.5 Summary and Future Perspectives References 12 Cytotoxicity of the Magnetic Quantum Dots 12.1 Introduction 12.2 Different Polymers and Their Biocompatibility 12.3 In-Vitro Cytotoxicity of QD-Polymer Composites 12.4 In-Vivo Cytotoxicity of QDs: Polymer Nanocomposites 12.5 Biocompatibility and Conjugation of QD-Polymer Nanocomposites 12.6 Summary References 13 Challenges and Future Prospects of Magnetic Quantum Dots 13.1 Introduction 13.2 Versatility and Applications 13.3 Magnetic Resonance-Based Bioimaging 13.4 Today’s Market of QDs and Associated Compounds 13.5 Bioassay Commercialization: Issues and Solutions 13.6 QDs’ Market in Microfluidics 13.7 One Stage Further: In the Direction of Creative Methods 13.8 Potential Future Vista 13.9 Lingering Issues, Difficulties, and Unsettled Debates 13.10 Summary References Index